top of page
Lucid

Our DiaComp pilot grant was selected for funding

Our pilot award to DiaComp was selected for funding! The goal of this pilot study is to test novel podocyte protective compounds that emerged from a phenotypic screen in an animal model of diabetic kidney disease


12 views0 comments

Recent Posts

See All

Super proud of our post doc Rachel Njeim for winning Oustanding Research Recognition Award at the International Podocyte Conference 2023. Next stop, small molecule therapeutic candidate for Diabetic K

Cole got accepted into the NSF sponsored summer research experience (REU) at UM! He will be working on an AI-based model for cancer diagnosis and extraction of relevant features using biomedical data.

We recently heard that Abdiel's NIH Diversity Supplement will be funded by NIH/NINDS. This will support Abdiel's graduate work in the Ali Lab and will contribute to his training as a scientist and a f

bottom of page